George A Zakhem1, Akshay N Pulavarty1, Jenna C Lester2, Mary L Stevenson3. 1. The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 222 East 41st Street, 24th Floor, New York, NY, 10017, USA. 2. University of California San Francisco, San Francisco, CA, USA. 3. The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 222 East 41st Street, 24th Floor, New York, NY, 10017, USA. Mary.Stevenson@nyumc.org.
Abstract
BACKGROUND: People of African, Asian, Hispanic or Latino, Pacific Islander, and Native Indian descent are considered people of color by the Skin of Color Society (SOCS). OBJECTIVES: In this study, we assess incidence, risk factors, clinical characteristics, histopathology, treatment, and survival for skin malignancies in people of color as defined by the SOCS, by systematically reviewing the literature. METHODS: An electronic literature search of the PubMed, EMBASE, and MEDLINE databases was performed. Articles published from 1 January 1990 through 12 December 2020 were included in the search. RESULTS: We identified 2666 publications potentially meeting the study criteria. Titles and abstracts of these studies were reviewed and 2353 were excluded. The full text of 313 articles were evaluated and 251 were included in this review. CONCLUSION: Differences in incidence, patterns, treatment, and survival exist among people of color for cutaneous malignancies. Further research and initiatives are needed to account for and mitigate these differences.
BACKGROUND: People of African, Asian, Hispanic or Latino, Pacific Islander, and Native Indian descent are considered people of color by the Skin of Color Society (SOCS). OBJECTIVES: In this study, we assess incidence, risk factors, clinical characteristics, histopathology, treatment, and survival for skin malignancies in people of color as defined by the SOCS, by systematically reviewing the literature. METHODS: An electronic literature search of the PubMed, EMBASE, and MEDLINE databases was performed. Articles published from 1 January 1990 through 12 December 2020 were included in the search. RESULTS: We identified 2666 publications potentially meeting the study criteria. Titles and abstracts of these studies were reviewed and 2353 were excluded. The full text of 313 articles were evaluated and 251 were included in this review. CONCLUSION: Differences in incidence, patterns, treatment, and survival exist among people of color for cutaneous malignancies. Further research and initiatives are needed to account for and mitigate these differences.
Authors: Steven Y He; Charles E McCulloch; W John Boscardin; Mary-Margaret Chren; Eleni Linos; Sarah T Arron Journal: J Am Acad Dermatol Date: 2014-06-11 Impact factor: 11.527
Authors: Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels Journal: AIDS Date: 2009-01-28 Impact factor: 4.177
Authors: Michael R Sargen; Elizabeth K Cahoon; Charles F Lynch; Margaret A Tucker; Alisa M Goldstein; Eric A Engels Journal: JAMA Dermatol Date: 2020-12-01 Impact factor: 10.282